Casterbridge Pharmaceuticals, Inc.

UEI
KBH4HU5NGTG5
CAGE
7K9W1
Primary NAICS
621511 Medical Laboratories
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Website
casterbridge-pharma.com

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Casterbridge Pharmaceuticals, Inc.'s 3 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Sbir PHS 2020-1, topic 084 entitled "antiviral drugs to cure chronic hepatitis b virus infection" Contract · 75N93020C00044 National Institute of Allergy and Infectious Diseases $297,245
Developing novel combination therapies for HSV genital infection. Grant · R41AI134187 National Institute of Allergy and Infectious Diseases $223,895
HIT-to-lead optimization of small-molecule inhibitors of herpes simplex viruses Grant · R41AI131739 National Institute of Allergy and Infectious Diseases $225,000

Quick answers

What is Casterbridge Pharmaceuticals, Inc.'s UEI?

Casterbridge Pharmaceuticals, Inc.'s Unique Entity ID (UEI) in SAM.gov is KBH4HU5NGTG5.

What is Casterbridge Pharmaceuticals, Inc.'s CAGE code?

Casterbridge Pharmaceuticals, Inc.'s CAGE code is 7K9W1.

What is Casterbridge Pharmaceuticals, Inc.'s primary NAICS code?

Casterbridge Pharmaceuticals, Inc.'s primary NAICS code is 621511 (Medical Laboratories).

Is Casterbridge Pharmaceuticals, Inc. registered in SAM.gov?

Casterbridge Pharmaceuticals, Inc.'s SAM.gov registration expired on June 28, 2022.

What is Casterbridge Pharmaceuticals, Inc.'s most recent federal award?

Casterbridge Pharmaceuticals, Inc.'s most recent federal contract award is Sbir PHS 2020-1, topic 084 entitled "antiviral drugs to cure chronic hepatitis b virus infection" (75N93020C00044), from National Institute of Allergy and Infectious Diseases, on August 21, 2020.

On GovTribe

See Casterbridge Pharmaceuticals, Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login